Refine
Year of publication
Document Type
- Preprint (574)
- Article (393)
- Conference Proceeding (7)
- Working Paper (4)
- Book (1)
- Part of a Book (1)
Has Fulltext
- yes (980)
Is part of the Bibliography
- no (980)
Keywords
- Heavy Ion Experiments (18)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- ALICE experiment (4)
- Hadron-Hadron Scattering (4)
- Heavy Ions (4)
- Quark-Gluon Plasma (4)
- ALICE (3)
- Jets and Jet Substructure (3)
- glioblastoma (3)
- pp collisions (3)
- Acute myeloid leukemia (2)
- Beauty production (2)
- Charm physics (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- HOD (2)
- Induction chemotherapy (2)
- Intensive care treatment (2)
- Jets (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Polymers (2)
- Single electrons (2)
- Survival (2)
- glioma (2)
- resilience (2)
- 900 GeV (1)
- ACLF (1)
- ALICE detector (1)
- AML (1)
- ASCT (1)
- ATR-FTIR (1)
- Abundance (1)
- Acute kidney failure (1)
- Alzheimer’s dementia (1)
- Amyloid-beta 42 (1)
- Analysis and statistical methods (1)
- Anti-kaon–nucleon physics (1)
- Anti-nuclei (1)
- Aphasia (1)
- Aphasie (1)
- Arcuate fascicle (1)
- Atomic and Molecular Physics (1)
- Autecology (1)
- BRAF (1)
- BRAF V600E (1)
- Baryonic resonances (1)
- Biomarkers (1)
- Bone marrow aspiration (1)
- Brain metastasis (1)
- Brain tumor (1)
- Breast cancer (1)
- CBC (1)
- CHIP (1)
- CLOUD experiment (1)
- CMS (1)
- CVID (1)
- Calorimeters (1)
- Cancer treatment (1)
- Centrality Class (1)
- Centrality Selection (1)
- Chemistry (1)
- Collective Flow (1)
- Comparison with QCD (1)
- Data processing methods (1)
- Ecology (1)
- Ecotoxicology (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Ellenberg indicator values (1)
- Elliptic flow (1)
- Environmental quality (1)
- Environmental sciences (1)
- European Society for Immunodeficiencies (ESID) (1)
- Fasciculus arcuatus (1)
- Feeding types (1)
- Femtoscopy (1)
- Festuco-Brometea (1)
- Fibre/foam sandwich radiator (1)
- Fluid overload (1)
- Freezeout (1)
- Freshwater (1)
- German PID-NET registry (1)
- Glioma (1)
- HBT (1)
- HVPG (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Heavy Ion Experiment (1)
- Heavy Quark Production (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Heavy-ion reactions (1)
- Hippocampal volume (1)
- Hirninfarkt (1)
- Holmes tremor (1)
- Hyperons (1)
- IgG substitution therapy (1)
- Imidacloprid (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Invariant Mass Distribution (1)
- Invertebrates (1)
- Ionisation energy loss (1)
- Ischemic stroke (1)
- Kaonic nuclei (1)
- Kollisionen schwerer Ionen (1)
- Lacunar (1)
- Lakunär (1)
- Lesions (1)
- Litter (1)
- Low energy QCD (1)
- MRI (1)
- Microplastic-biota interaction (1)
- Microplastics (1)
- Mid-rapidity (1)
- Mild cognitive impairment (1)
- Minimum Bias (1)
- Molecular matched therapy (1)
- Molecular profiling (1)
- Monitoring (1)
- Monte Carlo (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multiple stressors (1)
- Nanoplastics (1)
- Necrosis (1)
- Neural network (1)
- Non-small cell lung cancer (1)
- Nuclear modification factor (1)
- Nucleus (1)
- PID prevalence (1)
- PXA (1)
- PYTHIA (1)
- Partial wave analysis (1)
- Particle Correlations and Fluctuations (1)
- Pb–Pb (1)
- Performance of High Energy Physics Detectors (1)
- Peripheral blood smears (1)
- Phospho-tau (1)
- Plastic polymers (1)
- Plastics (1)
- Prediction (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Proton (1)
- Proton–proton (1)
- Pyrolysis GC–MS (1)
- QCD (1)
- QMD (1)
- Quantenmolekulardynamik (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Rapidity Range (1)
- Relapse surveillance (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Resolution Parameter (1)
- Review (1)
- Single muons (1)
- Stereotactic radiosurgery (1)
- Strangeness (1)
- Subcortical (1)
- Subkortikal (1)
- Suspended solids (1)
- Systematic Uncertainty (1)
- TR (1)
- Targeted therapy (1)
- Tau (1)
- Thermal desorption GC–MS (1)
- Time Projection Chamber (1)
- Toxicity (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Trigger (1)
- Vector (1)
- Vector Boson Production (1)
- Visual analysis (1)
- Water framework directive (1)
- Xenon-based gas mixture (1)
- acute decompensation (1)
- aerosol formation (1)
- aerosols (1)
- anti-angiogenic therapy (1)
- asset pricing (1)
- autologous stem cell transplantation (1)
- bevacizumab (1)
- cerebellar mutism (1)
- cerebellum (1)
- chemotherapy (1)
- cirrhosis (1)
- clonal dominance (1)
- clonal hematopoiesis (1)
- cortex, gray matter (1)
- credit risk (1)
- dE/dx (1)
- dabrafenib (1)
- diffusion tensor imaging (1)
- dispersal (1)
- ecological strategy (1)
- equity options (1)
- fractional anisotropy (1)
- gliomatosis cerebri growth pattern (1)
- heavy ion collisions (1)
- heavy ion experiments (1)
- hematopoietic stem cells (1)
- hematopoietic stress (1)
- hydrocephalus (1)
- hypoxia (1)
- intestinal manipulation (1)
- intraventricular chemotherapy (1)
- isolation (1)
- leptomeningeal disease (1)
- leptomeningeal metastases (1)
- leukemia (1)
- low risk anomaly (1)
- mean diffusivity (1)
- medulloblastoma (1)
- medulloblastoma resection (1)
- mowing (1)
- multiple sclerosis (1)
- nanoparticle growth (1)
- naturalness (1)
- neurosurgery (1)
- palatal tremor (1)
- pandemics (1)
- patterns of progression (1)
- perioperative ischemia (1)
- phenology (1)
- plant traits (1)
- pleomorphic xanthoastrocytoma (1)
- portal pressure (1)
- posterior fossa masses (1)
- ppK − (1)
- primary brain tumors (1)
- primary immunodeficiency (PID) (1)
- quant molekular dynamic (1)
- quark gluon plasma (1)
- rare disasters (1)
- registry for primary immunodeficiency (1)
- risk premia (1)
- skewness (1)
- social distance (1)
- somatic mutations (1)
- spectra (1)
- surgery (1)
- ventriculoperitoneal shunt (1)
- volatile organic compounds (1)
- √sN N = 2.76 TeV (1)
Institute
Limbic encephalitis (LE) is an autoimmune syndrome often associated with temporal lobe epilepsy. Recent research suggests that particular structural changes in LE depend on the type of the associated antibody and occur in both mesiotemporal gray matter and white matter regions. However, it remains questionable to what degree conventional diffusion tensor imaging (DTI)-methods reflect alterations in white matter microstructure, since these methods do not account for crossing fibers. To address this methodological shortcoming, we applied fixel-based analysis as a novel technique modeling distinct fiber populations. For our study, 19 patients with LE associated with autoantibodies against glutamic acid decarboxylase 65 (GAD-LE, mean age = 35.9 years, 11 females), 4 patients with LE associated with autoantibodies against leucine-rich glioma-inactivated 1 (LGI1-LE, mean age = 63.3 years, 2 females), 5 patients with LE associated with contactin-associated protein-like 2 (CASPR2, mean age = 57.4, 0 females), 20 age- and gender-matched control patients with hippocampal sclerosis (19 GAD-LE control patients: mean age = 35.1 years, 11 females; 4 LGI1-LE control patients: mean age = 52.6 years, 2 females; 5 CASPR2-LE control patients: mean age = 42.7 years, 0 females; 10 patients are included in more than one group) and 33 age- and gender-matched healthy control subjects (19 GAD-LE healthy controls: mean age = 34.6 years, 11 females; 8 LGI1-LE healthy controls: mean age = 57.0 years, 4 females, 10 CASPR2-LE healthy controls: mean age = 57.2 years, 0 females; 4 subjects are included in more than one group) underwent structural imaging and DTI at 3 T and neuropsychological testing. Patient images were oriented according to lateralization in EEG resulting in an affected and unaffected hemisphere. Fixel-based metrics fiber density (FD), fiber cross-section (FC), and fiber density and cross-section (FDC = FD · FC) were calculated to retrieve information about white matter integrity both on the micro- and the macroscale. As compared to healthy controls, patients with GAD-LE showed significantly (family-wise error-corrected, p < 0.05) lower FDC in the superior longitudinal fascicle bilaterally and in the isthmus of the corpus callosum. In CASPR2-LE, lower FDC in the superior longitudinal fascicle was only present in the affected hemisphere. In LGI1-LE, we did not find any white matter alteration of the superior longitudinal fascicle. In an explorative tract-based correlation analysis within the GAD-LE group, only a correlation between the left/right ratio of FC values of the superior longitudinal fascicle and verbal memory performance (R = 0.64, Holm-Bonferroni corrected p < 0.048) remained significant after correcting for multiple comparisons. Our results underscore the concept of LE as a disease comprising a broad and heterogeneous group of entities and contribute novel aspects to the pathomechanistic understanding of this disease that may strengthen the role of MRI in the diagnosis of LE.
Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment
(2014)
Background: Concerns about worsening memory (“memory concerns”; MC) and impairment in memory performance are both predictors of Alzheimer's dementia (AD). The relationship of both in dementia prediction at the pre-dementia disease stage, however, is not well explored. Refined understanding of the contribution of both MC and memory performance in dementia prediction is crucial for defining at-risk populations. We examined the risk of incident AD by MC and memory performance in patients with mild cognitive impairment (MCI).
Methods: We analyzed data of 417 MCI patients from a longitudinal multicenter observational study. Patients were classified based on presence (n = 305) vs. absence (n = 112) of MC. Risk of incident AD was estimated with Cox Proportional-Hazards regression models.
Results: Risk of incident AD was increased by MC (HR = 2.55, 95%CI: 1.33–4.89), lower memory performance (HR = 0.63, 95%CI: 0.56–0.71) and ApoE4-genotype (HR = 1.89, 95%CI: 1.18–3.02). An interaction effect between MC and memory performance was observed. The predictive power of MC was greatest for patients with very mild memory impairment and decreased with increasing memory impairment.
Conclusions: Our data suggest that the power of MC as a predictor of future dementia at the MCI stage varies with the patients' level of cognitive impairment. While MC are predictive at early stage MCI, their predictive value at more advanced stages of MCI is reduced. This suggests that loss of insight related to AD may occur at the late stage of MCI.
Das IAB-Betriebspanel ist eine jährliche Befragung im Auftrag des Instituts für Arbeitsmarkt- und Berufsforschung der Bundesagentur für Arbeit (IAB). Diese wird seit 1993 (Westdeutschland) bzw. 1996 (Ostdeutschland) von TNS Infratest Sozialforschung München jeweils zwischen Juni und Oktober durchgeführt. Grundgesamtheit der Bruttostichprobe ist die Betriebsdatei der Bundesagentur für Arbeit, welche alle Betriebe mit mindestens einem sozialversicherungspflichtig Beschäftigten enthält (2,09 Mio. Betriebe). Für die Stichprobenziehung wird die Grundgesamtheit nach 17 Branchen und 10 Betriebsgrößenklassen unterteilt. Mit Ausnahme der Betriebe ohne sozialversicherungspflichtig Beschäftigte sowie privater Haushalte mit weniger als fünf
sozialversicherungspflichtig Beschäftigten ist das IAB-Betriebspanel repräsentativ für alle Betriebe in Deutschland. Es werden (soweit wie möglich) jedes Jahr dieselben Betriebe befragt, was neben Querschnittsanalysen auch Längsschnittbetrachtungen erlaubt. Die Befragung erfolgt durch ein persönlich-mündliches Interview vor Ort. Der ausführliche 24-seitige Fragebogen erlaubt nicht nur eine Bestandsaufnahme betrieblicher Strukturen, Situationen und Problemzusammenhänge, sondern überdies werden Stimmungslagen und zukünftige Einschätzungen der Betriebe eingefangen.
Purpose: In secondary progressive Multiple Sclerosis (SPMS), global neurodegeneration as a driver of disability gains importance in comparison to focal inflammatory processes. However, clinical MRI does not visualize changes of tissue composition outside MS lesions. This quantitative MRI (qMRI) study investigated cortical and deep gray matter (GM) proton density (PD) values and T1 relaxation times to explore their potential to assess neuronal damage and its relationship to clinical disability in SPMS.
Materials and Methods: 11 SPMS patients underwent quantitative T1 and PD mapping. Parameter values across the cerebral cortex and deep GM structures were compared with 11 healthy controls, and correlation with disability was investigated for regions exhibiting significant group differences.
Results: PD was increased in the whole GM, cerebral cortex, thalamus, putamen and pallidum. PD correlated with disability in the whole GM, cerebral cortex, putamen and pallidum. T1 relaxation time was prolonged and correlated with disability in the whole GM and cerebral cortex.
Conclusion: Our study suggests that the qMRI parameters GM PD (which likely indicates replacement of neural tissue with water) and cortical T1 (which reflects cortical damage including and beyond increased water content) are promising qMRI candidates for the assessment of disease status, and are related to disability in SPMS.
Purpose: Diffuse cortical damage in relapsing–remitting multiple sclerosis (RRMS) is clinically relevant but cannot be directly assessed with conventional MRI. In this study, it was aimed to use diffusion tensor imaging (DTI) techniques with optimized intrinsic eddy current compensation to quantify and characterize cortical mean diffusivity (MD) and fractional anisotropy (FA) changes in RRMS and to analyze the distribution of these changes across the cortex.
Materials and Methods: Three-Tesla MRI acquisition, mapping of the MD providing information about the integrity of microstructural barriers and of the FA reflecting axonal density and surface-based analysis with Freesurfer were performed for 24 RRMS patients and 25 control subjects.
Results: Across the whole cortex, MD was increased in patients (p < 0.001), while surface-based analysis revealed focal cortical FA decreases. MD and FA changes were distributed inhomogeneously across the cortex, the MD increase being more widespread than the FA decrease. Cortical MD correlated with the Expanded Disability Status Scale (EDSS, r = 0.38, p = 0.03).
Conclusion: Damage of microstructural barriers occurs inhomogeneously across the cortex in RRMS and might be spatially more widespread than axonal degeneration. The results and, in particular, the correlation with the clinical status indicate that DTI might be a promising technique for the monitoring of cortical damage under treatment in larger clinical studies.
Acute kidney injury (AKI) complicates the clinical course of hospitalized patients by increasing need for intensive care treatment and mortality. There is only little data about its impact on AML patients undergoing intensive induction chemotherapy. In this study, we analyzed the incidence as well as risk factors for AKI development and its impact on the clinical course of AML patients undergoing induction chemotherapy. We retrospectively analyzed data from 401 AML patients undergoing induction chemotherapy between 2007 and 2019. AKI was defined and stratified according to KIDGO criteria by referring to a defined baseline serum creatinine measured on day 1 of induction chemotherapy. Seventy-two of 401 (18%) AML patients suffered from AKI during induction chemotherapy. AML patients with AKI had more days with fever (7 vs. 5, p = 0.028) and were more often treated on intensive care unit (45.8% vs. 10.6%, p < 0.001). AML patients with AKI had a significantly lower complete remission rate after induction chemotherapy and, with 402 days, a significantly shorter median overall survival (OS) (median OS for AML patients without AKI not reached). In this study, we demonstrate that the KIDGO classification allows mortality risk stratification for AML patients undergoing induction chemotherapy. Relatively mild AKI episodes have impact on the clinical course of these patients and can lead to chronic impairment of kidney function. Therefore, we recommend incorporating risk factors for AKI in decision-making considering nutrition, fluid management, as well as the choice of potentially nephrotoxic medication in order to decrease the incidence of AKI.
Treatment‐related complications contribute substantially to morbidity and mortality in acute myeloid leukemia (AML) patients undergoing induction chemotherapy. Although AML patients are susceptible to fluid overload (FO) (e.g., in the context of chemotherapy protocols, during sepsis treatment or to prevent tumor lysis syndrome), little attention has been paid to its role in AML patients undergoing induction chemotherapy. AML patients receiving induction chemotherapy between 2014 and 2019 were included in this study. FO was defined as ≥5% weight gain on day 7 of induction chemotherapy compared to baseline weight determined on the day of admission. We found FO in 23 (12%) of 187 AML patients undergoing induction chemotherapy. Application of >100 ml crystalloid fluids/kg body weight until day 7 of induction chemotherapy was identified as an independent risk factor for FO. AML patients with FO suffered from a significantly increased 90-day mortality rate and FO was demonstrated as an independent risk factor for 90-day mortality. Our data suggests an individualized, weight-adjusted calculation of crystalloid fluids in order to prevent FO-related morbidity and mortality in AML patients during induction chemotherapy. Prospective trials are required to determine the adequate fluid management in this patient population.
Coronavirus disease 2019 (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can affect multiple organs, among which is the circulatory system. Inflammation and mortality risk markers were previously detected in COVID-19 plasma and red blood cells (RBCs) metabolic and proteomic profiles. Additionally, biophysical properties, such as deformability, were found to be changed during the infection. Based on such data, we aim to better characterize RBC functions in COVID-19. We evaluate the flow properties of RBCs in severe COVID-19 patients admitted to the intensive care unit by using microfluidic techniques and automated methods, including artificial neural networks, for an unbiased RBC analysis. We find strong flow and RBC shape impairment in COVID-19 samples and demonstrate that such changes are reversible upon suspension of COVID-19 RBCs in healthy plasma. Vice versa, healthy RBCs resemble COVID-19 RBCs when suspended in COVID-19 plasma. Proteomics and metabolomics analyses allow us to detect the effect of plasma exchanges on both plasma and RBCs and demonstrate a new role of RBCs in maintaining plasma equilibria at the expense of their flow properties. Our findings provide a framework for further investigations of clinical relevance for therapies against COVID-19 and possibly other infectious diseases.
Editor's evaluation
This report illustrates a comprehensive account detailing the marked alteration of red blood cell (RBC) morphology that occurs with COVID-19 infection. A particularly important result is the observation that RBC morphology is dramatically affected by plasma from COVID-19 patients and reversible with plasma from healthy donors. The claims of the manuscript are well supported by the data, and the approaches used are thoughtful and rigorous. The results are important for consideration of the broader pathophysiology of COVID-19, particularly with regard to the impact on vascular biology and will be of interest to the readership of eLife.
Purpose: Molecular diagnostics including next generation gene sequencing are increasingly used to determine options for individualized therapies in brain tumor patients. We aimed to evaluate the decision-making process of molecular targeted therapies and analyze data on tolerability as well as signals for efficacy.
Methods: Via retrospective analysis, we identified primary brain tumor patients who were treated off-label with a targeted therapy at the University Hospital Frankfurt, Goethe University. We analyzed which types of molecular alterations were utilized to guide molecular off-label therapies and the diagnostic procedures for their assessment during the period from 2008 to 2021. Data on tolerability and outcomes were collected.
Results: 413 off-label therapies were identified with an increasing annual number for the interval after 2016. 37 interventions (9%) were targeted therapies based on molecular markers. Glioma and meningioma were the most frequent entities treated with molecular matched targeted therapies. Rare entities comprised e.g. medulloblastoma and papillary craniopharyngeoma. Molecular targeted approaches included checkpoint inhibitors, inhibitors of mTOR, FGFR, ALK, MET, ROS1, PIK3CA, CDK4/6, BRAF/MEK and PARP. Responses in the first follow-up MRI were partial response (13.5%), stable disease (29.7%) and progressive disease (46.0%). There were no new safety signals. Adverse events with fatal outcome (CTCAE grade 5) were not observed. Only, two patients discontinued treatment due to side effects. Median progression-free and overall survival were 9.1/18 months in patients with at least stable disease, and 1.8/3.6 months in those with progressive disease at the first follow-up MRI.
Conclusion: A broad range of actionable alterations was targeted with available molecular therapeutics.
However, efficacy was largely observed in entities with paradigmatic oncogenic drivers, in particular with BRAF mutations. Further research on biomarker-informed molecular matched therapies is urgently necessary.